Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Germany Clear all

142 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20053
20064
20072
20086
20096
20109
20117
20126
20136
20144
20157
20164
20178
201812
201911
20206
20219
20227
20239
20242
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Recruiting19
Terminated17
Active, not recruiting13
Unknown status8
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer14
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest8
Bristol-Myers Squibb6
Charite University, Berlin, Germany5
Eli Lilly and Company5
Hoffmann-La Roche5
AstraZeneca4
Exelixis4
Merck Sharp & Dohme LLC4
University Hospital Freiburg4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular142
Liver Neoplasms26
Cholangiocarcinoma9
Colorectal Neoplasms9
Neoplasms9
Carcinoma, Non-Small-Cell Lung7
Carcinoma5
Carcinoma, Renal Cell5
Endometrial Neoplasms5
Liver Diseases5

Trials

Showing 1 to 25 of 142. Each trial links to its page on Pharma Observatory.

42 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.